NASHVILLE, Tenn. & COLUMBUS, Ohio–(BUSINESS WIRE)–Raoul S. Concepcion, M.D., F.A.C.S., has joined U.S. Urology Partners within the newly shaped function of Chief Science Officer. One of many nation’s largest impartial suppliers of urological and associated specialty companies, U.S. Urology Partners gives normal urology, surgical procedures, superior most cancers therapy for prostate, bladder and kidney cancers, and different ancillary companies.
Dr. Concepcion will lead scientific operations of the quickly rising U.S. Urology Partners clinical network, which now contains 24 places by means of partners Central Ohio Urology Group and Associated Medical Professionals of NY. Dr. Concepcion has many years of expertise as a pioneer and clinician on the forefront of the urology trade, together with serving as a founding board member and former President of LUGPA, the premier nonprofit affiliation and advocate for impartial urology practices.
Mark Cherney, Chief Executive Officer of U.S. Urology Partners, acknowledged, “We’re excited that Dr. Raoul Concepcion has joined U.S. Urology Partners as Chief Science Officer. His longstanding expertise in urological medical analysis packages and analytics will help U.S. Urology Partners and its partner practices in offering optimum take care of sufferers. Dr. Concepcion shall be notably useful in advancing our precision medication program, together with genomics, genetic testing and counseling.”
As urology practices search an alternative choice to hospital acquisition that can enable them to deal with the observe of drugs slightly than enterprise issues, they’re turning to U.S. Urology Partners. Fashioned in 2018, U.S. Urology Partners supports urology practices by means of an experienced team of healthcare executives and assets and is funded by NMS Capital.
Raoul S. Concepcion, M.D., F.A.C.S., Chief Science Officer, acknowledged, “U.S. Urology Companions is devoted to offering state-of-the-art take care of the urologic affected person by offering wanted operational assist and making an attempt to standardize care throughout their suppliers. As Chief Science Officer, I shall be working alongside key physicians from the member practices to determine a precision medication most cancers administration mannequin for affiliated groups that can incorporate proof based mostly therapy pointers, set up a medical genomic medication service and construct a central medical trials initiative. The aim is to reinforce affected person care and advance science, which in flip gives added worth to companion practices.”
He added, “Establishing a precision medication platform will allow the workforce at U.S. Urology Companions and its affiliated urology groups to ship the right therapy to the right affected person. The previous 10 years has seen the emergence of incorporating superior most cancers administration into urology practices. Now, this additionally mandates the understanding of genetic and genomic testing to optimize take care of these sufferers, very a lot akin to the usual of care related to breast and colorectal tumors. Thus, staying present and abreast of the quickly evolving information presents operational challenges for the busy clinician that shall be supported by U.S. Urology Companions and its Medical Advisory Group, which I’m proud to be part of.“
A local of central Ohio, Dr. Concepcion has been a Medical Assistant Professor within the Division of Urology, Vanderbilt College of Drugs. He was a Basic Surgical procedure and Urology Resident from 1984 to 1989 and served as Chief Urology Resident from 1989 to 1990. Moreover, he was a analysis fellow within the Mild Laboratories at Vanderbilt. Extra lately, he has accomplished The Metropolis of Hope Intensive Course on Most cancers Threat Evaluation for hereditary most cancers and genomic testing. He has been in observe since 1990, along with his main medical curiosity being Urologic Oncology, specializing in superior prostate and bladder most cancers and decrease urinary tract reconstruction, in addition to the function of genomics and genetic testing in GU tumors. He’s Board Licensed by the American Urological Affiliation (AUA) and is a member of that group, in addition to the Southeastern Part of the AUA, Society of Urologic Oncology, American Faculty of Surgeons and the Nashville Surgical Society.
From a analysis perspective, Dr. Concepcion has been actively concerned in fundamental science and medical analysis since his days at Vanderbilt. Dr. Concepcion has been both the principal investigator (PI) or Co-PI on many medical trials for the reason that Nineties. The main focus as of latest has been in superior prostate most cancers, in addition to biomarker growth. He co-founded CUSP, a urology particular medical trials administration firm that makes a speciality of website and affected person accrual for the pharmaceutical and biolab industries. From an trade perspective, Dr. Concepcion serves as an advisor, guide or speaker for a lot of firms concerned within the prognosis and administration of prostate most cancers. He’s creating a precision medication complete prostate most cancers program for U.S. Urology Companions and affiliated teams, centered on genomic testing, pathway growth, information aggregation and medical trial work.
About U.S. Urology Companions
U.S. Urology Partners is among the nation’s largest impartial suppliers of urology and associated specialty companies, together with normal urology, surgical procedures, superior most cancers therapy, and different ancillary companies. By Central Ohio Urology Group and Associated Medical Professionals of NY, the U.S. Urology Companions clinical network now consists of 24 places of work, together with a state-of-the-art, urology-specific ambulatory surgical procedure heart that is among the first within the nation to supply robotic surgical procedure. U.S. Urology Partners was shaped to support urology practices by means of an experienced team of healthcare executives and assets, whereas serving as a platform upon which NMS Capital intends to construct a number one supplier of urological companies by means of an acquisition technique. The U.S. Urology Partners company places of work are in Nolensville, Tennessee, and Gahanna, Ohio, simply outdoors of Nashville and Columbus. For extra details about U.S. Urology Companions, please go to the corporate’s web site at www.us-uro.com.